Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003068206 | SCV003452330 | benign | Alagille syndrome due to a JAG1 point mutation | 2023-08-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004070323 | SCV003628177 | uncertain significance | Cardiovascular phenotype | 2022-06-09 | criteria provided, single submitter | clinical testing | The c.1414C>T (p.R472C) alteration is located in exon 12 (coding exon 12) of the JAG1 gene. This alteration results from a C to T substitution at nucleotide position 1414, causing the arginine (R) at amino acid position 472 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |